Correlation Between Haemonetics and Akoya Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Haemonetics and Akoya Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Haemonetics and Akoya Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Haemonetics and Akoya Biosciences, you can compare the effects of market volatilities on Haemonetics and Akoya Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Haemonetics with a short position of Akoya Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Haemonetics and Akoya Biosciences.

Diversification Opportunities for Haemonetics and Akoya Biosciences

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Haemonetics and Akoya is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Haemonetics and Akoya Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akoya Biosciences and Haemonetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Haemonetics are associated (or correlated) with Akoya Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akoya Biosciences has no effect on the direction of Haemonetics i.e., Haemonetics and Akoya Biosciences go up and down completely randomly.

Pair Corralation between Haemonetics and Akoya Biosciences

Considering the 90-day investment horizon Haemonetics is expected to generate 0.43 times more return on investment than Akoya Biosciences. However, Haemonetics is 2.33 times less risky than Akoya Biosciences. It trades about 0.2 of its potential returns per unit of risk. Akoya Biosciences is currently generating about -0.16 per unit of risk. If you would invest  7,573  in Haemonetics on August 27, 2024 and sell it today you would earn a total of  982.00  from holding Haemonetics or generate 12.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Haemonetics  vs.  Akoya Biosciences

 Performance 
       Timeline  
Haemonetics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Haemonetics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, Haemonetics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Akoya Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Akoya Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Akoya Biosciences is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Haemonetics and Akoya Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Haemonetics and Akoya Biosciences

The main advantage of trading using opposite Haemonetics and Akoya Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Haemonetics position performs unexpectedly, Akoya Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akoya Biosciences will offset losses from the drop in Akoya Biosciences' long position.
The idea behind Haemonetics and Akoya Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum